Live Breaking News & Updates on George Apostol|Page 2

Stay updated with breaking news from George apostol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Greenlights Phase 3 Trials of Quilience for Narcolepsy

NLS Pharmaceutics received FDA authorization to proceed with the phase 3 AMAZE program for Quilience (mazindol ER) for narcolepsy treatment. ....

George Apostol , Alex Zwyer , Drug Administration , European Medicines Agency , Pharmaceutics Ltd , Orphan Disease Designation , European Medicines ,

NLS Pharmaceutics Receives Green Light from the U.S. FDA to Proceed with Phase 3 Clinical Program (AMAZE) for Quilience(R) (Mazindol ER) for the Treatment of Narcolepsy

NLS Pharmaceutics Receives Green Light from the U.S. FDA to Proceed with Phase 3 Clinical Program (AMAZE) for Quilience(R) (Mazindol ER) for the Treatment of Narcolepsy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , George Apostol , Marianne Lambertson , Alex Zwyer , European Medicines Agency , Drug Administration , American Academy Of Sleep Medicine , Exchange Commission , Pharmaceutics Ltd , Research Society , Wall Street , Chief Executive Officer , American Academy , Sleep Medicine , Sleep Research Society , Chief Medical , Idiopathic Hypersomnia , Orphan Disease Designation , Mazindol Controlled Release , Orphan Drug Designations ,

NLS Pharmaceutics AG: NLS Pharmaceutics Receives Green Light from the U.S. FDA to Proceed with Phase 3 Clinical Program for Quilience for the Treatment of Narcolepsy

ZURICH, SWITZERLAND / ACCESSWIRE / May 2, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development ....

United States , George Apostol , Marianne Lambertson , Alex Zwyer , European Medicines Agency , Drug Administration , American Academy Of Sleep Medicine , Exchange Commission , Pharmaceutics Ltd , Research Society , Chief Executive Officer , American Academy , Sleep Medicine , Sleep Research Society , Chief Medical , Idiopathic Hypersomnia , Orphan Disease Designation , Mazindol Controlled Release , Orphan Drug Designations ,

NLS Pharmaceutics (NLSP) Cleared by FDA to Proceed with Phase 3 Clinical Program for Quilience

NLS Pharmaceutics (NLSP) Cleared by FDA to Proceed with Phase 3 Clinical Program for Quilience
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Alex Zwyer , Marianne Lambertson , George Apostol , Research Society , Pharmaceutics Ltd , Exchange Commission , American Academy Of Sleep Medicine , Drug Administration , European Medicines Agency , Chief Executive Officer , American Academy , Sleep Medicine , Sleep Research Society , Chief Medical , Idiopathic Hypersomnia , Orphan Disease Designation , Mazindol Controlled Release , Orphan Drug Designations ,

NLS Pharmaceutics (NLSP) Presents Latest Preclinical Pipeline Data

NLS Pharmaceutics (NLSP) Presents Latest Preclinical Pipeline Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Jean Charles Bizot , Marianne Lambertson , Norinne Lacerda Queiroz , Fabrice Trovero , Laurent Benel , Sabrina David , Eric Konofal , George Apostol , Julie Combeau , Bruno Figadere , American Society Of Clinical Psychopharmacology , Pharmaceutic Research Presentations , Pharmaceutics Ltd , Wall Street , American Society , Clinical Psychopharmacology , Chief Scientific Officer , Research Presentations , Fabienne Mass ,